Related Experiment Video
Updated: Feb 3, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
GLI1 promotes cancer stemness through intracellular signaling pathway PI3K/Akt/NFκB in colorectal adenocarcinoma
Zhaoting Yang1, Chengye Zhang2, Wenbo Qi1
1Institute for Regenerative Medicine, Yanbian University College of Medicine, Yanji, China; Department of Pathology, Yan bian University College of Medicine, Yanji 133002, Jilin Province, China.
Abstract:
The role of Hedgehog (HH)/ glioma-associated oncogene homolog 1 (GLI1) pathway has been implicated in a variety of cancer entities, and the targeted pathway inhibition mediated by GLI1 is of therapeutic relevance. However, its oncogenicity and cross-talks with other cancer pathways including PI3K/Akt/NFκB, which modulates the HH/GLI1 signal strength, have rarely been explored in colorectal adenocarcinoma. We assessed the expression of GLI1 and its relationship with other cancer stemness genes, cell cycle markers, epithelial-mesenchymal transition (EMT), PI3K/Akt/NFκB signaling pathway genes, and HIF1α in 100 paraffin-embedded colorectal adenocarcinoma tissue samples using immunohistochemistry. We further addressed the effect of GLI1 on EMT, cell cycle, and its putative interaction with the PI3K/Akt/NFκB cascade in colorectal adenocarcinoma cell lines. The expression of GLI1 in colorectal adenocarcinoma tissues was found to correlate with the clinical stages, and distant metastasis. Moreover, GLI1 was found to be an independent predictor of poor overall survival and disease-free survival in colorectal adenocarcinoma. GLI1-expressing cancer cells also expressed their representative cancer stem-like cell (CSC) markers (SOX9 and CD133), as well as HIF1α. GLI1 expression was also strongly linked to EMT-related and PI3K/Akt/NFκB signaling genes. Downregulation of GLI1 by inhibitor treatment in colorectal adenocarcinoma cell lines resulted in reduced expression of CSC markers, cell clonogenicity, S-phase subpopulations, as well as the migration and invasion ability. Importantly, Akt inhibitor Perifosine significantly inhibited the expression of pAkt and GLI1 in colorectal adenocarcinoma cells. Combination of GLI1 inhibitor GANT61 and NFκB p65 inhibitor QZN exhibited much higher inhibition compared to using any of them individually on colorectal adenocarcinoma cells. We suggested that GLI1 may be a novel stem cell marker, and cancer stemness was activated via PI3K/Akt/NFκB pathway. In addition, co-targeting GLI1 and PI3K/Akt/NFκB signaling simultaneously might provide an alternative therapeutic strategy for colorectal adenocarcinoma patients.
Insights
Glioma-associated oncogene homolog 1 (GLI1) is linked to poor survival in colorectal cancer. Targeting GLI1 and the PI3K/Akt/NFκB pathway may offer new therapeutic strategies for colorectal adenocarcinoma.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Therapeutics
Background:
- The Hedgehog (HH)/glioma-associated oncogene homolog 1 (GLI1) pathway is implicated in various cancers.
- Its role and interactions with pathways like PI3K/Akt/NFκB in colorectal adenocarcinoma are under-explored.
- GLI1's oncogenic potential and cross-talks require further investigation for therapeutic relevance.
Purpose of the Study:
- To assess GLI1 expression and its correlation with clinical parameters and other cancer markers in colorectal adenocarcinoma.
- To investigate the effect of GLI1 on cancer stemness, EMT, cell cycle, and its interaction with the PI3K/Akt/NFκB pathway.
- To evaluate the therapeutic potential of targeting GLI1 and the PI3K/Akt/NFκB pathway in colorectal adenocarcinoma.
Main Methods:
- Immunohistochemistry was used to analyze GLI1 expression in 100 colorectal adenocarcinoma tissue samples.
- Correlation analysis was performed with cancer stemness genes, cell cycle markers, EMT markers, PI3K/Akt/NFκB pathway genes, and HIF1α.
- In vitro studies using colorectal adenocarcinoma cell lines assessed the effects of GLI1 inhibition and combined pathway inhibition.
Main Results:
- GLI1 expression correlated with advanced clinical stages and distant metastasis, predicting poor overall and disease-free survival.
- GLI1-expressing cells showed increased cancer stem-like cell markers (SOX9, CD133), HIF1α, and EMT-related genes.
- GLI1 inhibition reduced CSC markers, clonogenicity, S-phase, migration, and invasion; Akt inhibitor Perifosine reduced pAkt and GLI1; combined GLI1 and NFκB inhibition showed synergistic effects.
Conclusions:
- GLI1 may serve as a novel stem cell marker in colorectal adenocarcinoma, with cancer stemness activated via the PI3K/Akt/NFκB pathway.
- GLI1 expression is significantly associated with aggressive clinicopathological features and poor prognosis.
- Simultaneous co-targeting of GLI1 and PI3K/Akt/NFκB signaling presents a promising therapeutic strategy for colorectal adenocarcinoma.
More Related Videos
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Intracellular Signaling Cascades
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Intracellular Signaling Affects Focal Adhesions
Some...

